Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Inflammatory Bowel Disease Topic Center

Conference Coverage
06/22/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Immune mediated inflammatory disease symptoms are more than just physiological, extending from anxiety to depression to fatigue.
Immune mediated inflammatory disease symptoms are more than just physiological, extending from anxiety to depression to fatigue.
Immune mediated inflammatory...
06/22/2023
Autoimmune
Uma Mahadevan, MD
Conference Coverage
06/21/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Uma Mahadevan, MD, and Christopher Robinson, MD, discuss the importance of preconception counseling for a patient with immune-mediated inflammatory disease to boost their chances of achieving and maintaining a healthy pregnancy.
Uma Mahadevan, MD, and Christopher Robinson, MD, discuss the importance of preconception counseling for a patient with immune-mediated inflammatory disease to boost their chances of achieving and maintaining a healthy pregnancy.
Uma Mahadevan, MD, and...
06/21/2023
Autoimmune
Stephen Hanauer
Conference Coverage
04/28/2023
A panel led by inflammatory bowel disease specialists Stephen B. Hanauer and Adam Cheifetz reviewed the importance of working to break through a therapeutic ceiling and developing precision medicine in propelling the practice of...
A panel led by inflammatory bowel disease specialists Stephen B. Hanauer and Adam Cheifetz reviewed the importance of working to break through a therapeutic ceiling and developing precision medicine in propelling the practice of...
A panel led by inflammatory...
04/28/2023
Autoimmune
multidisciplinary healthcare
Conference Coverage
04/27/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Comanagement strategies are often beneficial to patients with immune-mediated inflammatory disease since they are at a higher risk of developing other autoimmune conditions.
Comanagement strategies are often beneficial to patients with immune-mediated inflammatory disease since they are at a higher risk of developing other autoimmune conditions.
Comanagement strategies are...
04/27/2023
Autoimmune
Stephen Hanauer
Conference Coverage
04/26/2023
Dr Hanauer emphasizes how a number of potential human models can be used to more accurately evaluate the pathogenesis of inflammatory bowel disease by studying human patients rather than mice.
Dr Hanauer emphasizes how a number of potential human models can be used to more accurately evaluate the pathogenesis of inflammatory bowel disease by studying human patients rather than mice.
Dr Hanauer emphasizes how a...
04/26/2023
Autoimmune
Gil Melmed, MD
Conference Coverage
12/21/2022
Dr Melmed reviews the results of studies regarding the response to and safety of COVID-19 vaccination among patients with IBD.
Dr Melmed reviews the results of studies regarding the response to and safety of COVID-19 vaccination among patients with IBD.
Dr Melmed reviews the results of...
12/21/2022
Autoimmune
News
08/31/2021
Researchers in France investigated whether treating inflammatory arthritis with interleukin-17 inhibitors might increase risk of inflammatory bowel disease.
Researchers in France investigated whether treating inflammatory arthritis with interleukin-17 inhibitors might increase risk of inflammatory bowel disease.
Researchers in France...
08/31/2021
Autoimmune
News
08/26/2021

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Patients with IMIDs acknowledge the importance of nutrition and its importance on symptom management but need more dietary advice from HCPs.
Patients with IMIDs acknowledge the importance of nutrition and its importance on symptom management but need more dietary advice from HCPs.
Patients with IMIDs acknowledge...
08/26/2021
Autoimmune
News
08/20/2021

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Risk of developing inflammatory bowel disease is greater among new users of IL-17 inhibitors than among new users of apremilast but not in etanercept new-users.
Risk of developing inflammatory bowel disease is greater among new users of IL-17 inhibitors than among new users of apremilast but not in etanercept new-users.
Risk of developing inflammatory...
08/20/2021
Autoimmune
Jason Schairer, MD, on Dermatologic Manifestations in IBD
Q&As
06/06/2021
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
In this Q&A, Dr Schairer answers...
06/06/2021
Autoimmune
News
01/27/2021
The 27 consensus statements address prognostic factors for surgery, complications, chronically active pediatric Crohn disease, and hospitalization.
The 27 consensus statements address prognostic factors for surgery, complications, chronically active pediatric Crohn disease, and hospitalization.
The 27 consensus statements...
01/27/2021
Autoimmune

Advertisement

Advertisement

Advertisement